Infection occurs when organism is attacked by disease causing agent, they multiply in the host body & produce toxins. Infection may remain localised or it can be spread through blood or lymphatic vessels to overall body. Infections are caused by infectious agents like virus, viroid, bacteria, prions etc. Host body fights infections by provoking immune system. Infections can be treated by medications like antibiotics, antivirals, antifungals etc.
The report "Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022", The global infectious disease diagnostics market is expected to reach USD 19.35 Billion by 2022 from USD 14.73 Billion in 2017, at a CAGR of 5.6%. The increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics are some the factors driving the growth of this market.